Table 3.
Value | SE | DF | t-value | p-value | |
Baseline_m14 vs. m14_m26 | 9.810 | 4.216 | 700 | 2.327 | 0.02 |
Baseline_m14 vs. m26_m38 | 3.155 | 6.598 | 700 | 0.478 | 0.63 |
Age at symptom onset | 0.034 | 0.034 | 146 | 0.982 | 0.33 |
Walking distance at baseline | –0.044 | 0.017 | 146 | –2.660 | 0.01 |
Age at start of treatment | 0.011 | 0.015 | 146 | 0.704 | 0.48 |
SMN2 copy number | –17.901 | 5.875 | 146 | –3.047 | 0.003 |
Sex M | –2.683 | 5.656 | 146 | –0.474 | 0.64 |
Fatigue | –6.894 | 3.574 | 700 | –1.929 | 0.05 |
Inferential analysis evaluates the effect of age at diagnosis, age at start of treatment, SMN2 copy number (≤3 SMN2 copies vs.≥4 SMN2 copies), gender, baseline 6MWT, and past time from baseline on changes in 6MWT. *Standard error = SE; degree of freedom = DF.